{"pmid":32401694,"title":"Flying by the Seat of our Pants -Is low Dose Radiation Therapy for COVID-19 an Option?","text":["Flying by the Seat of our Pants -Is low Dose Radiation Therapy for COVID-19 an Option?","Int J Radiat Biol","Schaue, Dorthe","McBride, William H","32401694"],"journal":"Int J Radiat Biol","authors":["Schaue, Dorthe","McBride, William H"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32401694","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1080/09553002.2020.1767314","topics":["Treatment"],"weight":1,"_version_":1666714494891458560,"score":9.490897,"similar":[{"pmid":32388805,"title":"Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?","text":["Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?","In the current dismal situation of the COVID-19 pandemic, effective management of patients with pneumonia and acute respiratory distress syndrome is of vital importance. Due to the current lack of effective pharmacological concepts, this situation has caused interest in (re)considering historical reports on the treatment of patients with low-dose radiation therapy for pneumonia. Although these historical reports are of low-level evidence per se, hampering recommendations for decision-making in the clinical setting, they indicate effectiveness in the dose range between 0.3 and 1Gy, similar to more recent dose concepts in the treatment of acute and chronic inflammatory/degenerative benign diseases with, e.g., a single dose per fraction of 0.5Gy. This concise review aims to critically review the evidence for low-dose radiation treatment of COVID-19 pneumopathy and discuss whether it is worth investigating in the present clinical situation.","Strahlenther Onkol","Rodel, Franz","Arenas, Meritxell","Ott, Oliver J","Fournier, Claudia","Georgakilas, Alexandros G","Tapio, Soile","Trott, Klaus-Rudiger","Gaipl, Udo S","32388805"],"abstract":["In the current dismal situation of the COVID-19 pandemic, effective management of patients with pneumonia and acute respiratory distress syndrome is of vital importance. Due to the current lack of effective pharmacological concepts, this situation has caused interest in (re)considering historical reports on the treatment of patients with low-dose radiation therapy for pneumonia. Although these historical reports are of low-level evidence per se, hampering recommendations for decision-making in the clinical setting, they indicate effectiveness in the dose range between 0.3 and 1Gy, similar to more recent dose concepts in the treatment of acute and chronic inflammatory/degenerative benign diseases with, e.g., a single dose per fraction of 0.5Gy. This concise review aims to critically review the evidence for low-dose radiation treatment of COVID-19 pneumopathy and discuss whether it is worth investigating in the present clinical situation."],"journal":"Strahlenther Onkol","authors":["Rodel, Franz","Arenas, Meritxell","Ott, Oliver J","Fournier, Claudia","Georgakilas, Alexandros G","Tapio, Soile","Trott, Klaus-Rudiger","Gaipl, Udo S"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32388805","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s00066-020-01635-7","keywords":["anti-inflammatory","covid-19","low-dose radiation therapy","pneumonia","sars-cov-2"],"topics":["Treatment"],"weight":1,"_version_":1666428892747923456,"score":54.739243},{"pmid":32342871,"pmcid":"PMC7194710","title":"Is low dose radiation therapy a potential treatment for COVID-19 pneumonia?","text":["Is low dose radiation therapy a potential treatment for COVID-19 pneumonia?","Radiother Oncol","Kirkby, Charles","Mackenzie, Marc","32342871"],"journal":"Radiother Oncol","authors":["Kirkby, Charles","Mackenzie, Marc"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342871","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.radonc.2020.04.004","topics":["Treatment"],"weight":1,"_version_":1666138495029084162,"score":53.800163},{"pmid":32338559,"title":"Low dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence?","text":["Low dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence?","Int J Radiat Biol","Salomaa, Sisko","Cardis, Elisabeth","Bouffler, Simon D","Atkinson, Michael J","Hamada, Nobuyuki","32338559"],"journal":"Int J Radiat Biol","authors":["Salomaa, Sisko","Cardis, Elisabeth","Bouffler, Simon D","Atkinson, Michael J","Hamada, Nobuyuki"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32338559","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1080/09553002.2020.1762020","keywords":["covid-19","circulatory disease","low dose radiation therapy","lung cancer","pneumonia"],"topics":["Treatment"],"weight":1,"_version_":1666138494243700736,"score":52.330624},{"pmid":32342874,"pmcid":"PMC7169900","title":"Low dose radiation therapy for COVID-19 pneumonia: a double-edged sword.","text":["Low dose radiation therapy for COVID-19 pneumonia: a double-edged sword.","Radiother Oncol","Kefayat, Amirhosein","Ghahremani, Fatemeh","32342874"],"journal":"Radiother Oncol","authors":["Kefayat, Amirhosein","Ghahremani, Fatemeh"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342874","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.radonc.2020.04.026","topics":["Treatment"],"weight":1,"_version_":1666138495024889856,"score":50.146946},{"pmid":32451973,"title":"Low-dose radiation therapy: could it be a game-changer for COVID-19?","text":["Low-dose radiation therapy: could it be a game-changer for COVID-19?","Clin Transl Oncol","Montero, A","Arenas, M","Algara, M","32451973"],"journal":"Clin Transl Oncol","authors":["Montero, A","Arenas, M","Algara, M"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451973","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s12094-020-02401-y","weight":0,"_version_":1667881798527352832,"score":49.173107}]}